Reginald L. Hardy - 31 Dec 2021 Form 4 Insider Report for Brickell Biotech, Inc.

Role: CHAIRMAN OF THE BOARD, Director
Signature: /s/ Christine G. Long, Attorney-in-Fact for Reginald L. Hardy (power of attorney previously filed)
Issuer symbol: N/A
Transactions as of: 31 Dec 2021
Net transactions value: -$3,475
Form type: 4
Filing time: 25 Feb 2022, 15:37:02 UTC
Previous filing: 27 Jul 2021
Next filing: 17 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FRTX	Common Stock	Tax liability	$3,475	-15,180	-3.4%	$0.2289	433,231	31 Dec 2021	Direct	F1
holding	FRTX	Common Stock						21,826	31 Dec 2021	By Spouse (spouse jointly owns with other Individual)
holding	FRTX	Common Stock						17,260	31 Dec 2021	By Self as Trustee
holding	FRTX	Common Stock						9,261	31 Dec 2021	By Spouse
holding	FRTX	Common Stock						17,260	31 Dec 2021	By Spouse as Trustee
holding	FRTX	Common Stock						266,447	31 Dec 2021	By Self as General Partner

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs.